KPIT Technologies' employees face pay cuts of 10-50%

The pay cuts will be in the range of 10-50 percent from April to September

Swathi Moorthy

May 14, 2020 / 10:02 PM IST

live

bselive
nselive

Volume

Todays L/H

IT/ITeS firm KPIT Technologies said it will cut employee salaries as its business has been hit by the novel coronavirus, or COVID-19, pandemic. The Pune labour commission has issued a notice to the company regarding the same.

The pay cuts will be in the range of 10-50 percent from April to September. The company employs over 6,000 people.

In an email to employees, Kishor Patil, Group CEO, said, “The overarching approach, as stated earlier, is that of safeguarding jobs over maintaining individual salaries and levying significantly higher cuts for senior grades than those for junior grades.”

While the chairman will not draw any variable component, others will face a cut of 10-50 percent depending on one's job band. "Compensation structure will also be changed as variable pay and special allowance components will be deducted depending on your job band. Any remaining amount will be deducted from the fixed salary, the mail added.

Harpreet Saluja, National Information Technology Senate (NITES), an IT Union, said more than 200 employees have been asked to work part-time and their salary has been reduced by 50 percent.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show